OUTCOME OF USING PLATELET, PLASMA AND GROWTH FACTORS AS AN ORTHOBIOLOGIC DERIVATIVE TO AVOID INVASIVE SURGICAL PROCEDURES FOR TREATING KNEE OSTEOARTHRITIS AMONG ELDERLY PATIENTS

  • Thana Turjane Biomedical Technology Research and Development Center, Police General Hospital
  • Pamok Saengsirinavin Biomedical Technology Research and Development Center, Police General Hospital
  • Chaivat Sriratanavudhi Biomedical Technology Research and Development Center, Police General Hospital
  • Vorasilp Cheeva-akrapan Biomedical Technology Research and Development Center, Police General Hospital
  • Wanpen Larpaiwong Biomedical Technology Research and Development Center, Police General Hospital
  • Jongjate Aojanepong THAI StemLife
Keywords: Orthobiologics, Plasma, Platelet, Growth factor, Knee osteoarthritis

Abstract

Background: The application of platelet, plasma and growth factors (PP&GF) is an intra-articular orthobiologic intervention that has been proven to be safe, having less systemic complications compared with conventional treatments and could constitute an option for treating elderly patients with knee osteoarthritis (OA). However, an intermediate result of using PP&GF has yet to be well established.

Objectives: This study aimed to report the survival analysis of 24-month follow-up treatment using PP&GF among elderly patients with knee OA as primary outcome. The secondary outcomes were functional improvement in terms of international knee documentation committee (IKDC) score, Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) score and visual analog scale (VAS) pain score.

Methods: A prospective cohort study was performed among patients with knee OA (Kellgren and Lawrence (KL) grade I-IV), aged more than 65 years who did not respond to conservative treatments. All patients received intra-articular PP&GF treatment and were followed up to 24 months. Primary outcome was recorded as any surgical treatment at any time point post-PP&GF injection. Secondary outcomes including IKDC, WOMAC and VAS pain score were also assessed.

Results: A total of 184 participants were enrolled in this study. The overall survival rate of patients not undergoing any surgical procedures during 24-month follow-up was 87.50%±2.44%. The mean IKDC, WOMAC and VAS pain scores were 39.59±0.58, 55.9±1.09 and 6.63±0.13, respectively at baseline while those at 24-month follow-up were 46.77±0.81, 38.32±1.33 and 4.92±0.13, respectively. The mean platelet concentrations before and after centrifugation were 1.85x105 cells/μL (1.20-3.36x105 cells/μL) and 1.4x106 cells/μL (5.80x105-3.5 x106) cells/μL, respectively, which showed final PP&GF products contained 6-10 times higher platelet concentration than those in the peripheral blood.

Conclusion: Intra-articular injection of PP&GF is a potential treatment for severe knee OA especially among elderly patients. This method provided 87.50% survivorship from surgical intervention at 24-month follow-up. Most patients improved both pain and functional outcomes. We propose that the optimal preparation technique for PP&GF is the key step for improving patients’ clinical outcomes and regaining their quality of lives.

Downloads

Download data is not yet available.

References

Safiri S, Kolahi A- A, Smith E, Hill C, Bettampadi D, Mansournia MA. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis 2020; 79: 819-28. DOI: https://doi.org/10.1136/bmj.m791

Eilik H, Dogu B, Yilmaz F, Begoglu FA, Kuran B. The efficiency of platelet-rich plasma treatment in patients with knee osteoarthritis. J Back Musculoskelet Rehabil 2020; 33: 127-38. DOI: https://doi.org/10.3233/BMR-181374

Bruyere O, Paveka K, Rovati LC, Gatterova J, Giacovelli G, Olejarova M, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomized, placebocontrolled trials. Osteoarthritis Cartilage 2008; 16: 254-60. DOI: https://doi.org/10.1016/j.joca.2007.06.011

Robinson DM, Eng C, Makovitch S, Rothenberg JB, DeLuca S, Douglas S. Non-operative orthobiologic use for rotator cuff disorders and glenohumeral osteoarthritis: a systematic review. J Back Musculoskelet Rehabil 2021; 34: 17-32. DOI: https://doi.org/10.3233/BMR-201844

Boutefnouchet T, Puranik G, Holmes E, Bell KM. Hylan GF-20 Viscosupplementation in the treatment of symptomatic osteoarthritis of the knee: Clinical effect survivorship at 5 years. Knee Surg Relat Res 2017; 29: 129-36. DOI: https://doi.org/10.5792/ksrr.16.061

Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidermiology of revision total knee arthrtoplasty in the United States. J Arthroplasty 2017; 32: 2563-8. DOI: https://doi.org/10.1016/j.arth.2017.03.066

Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample. J Rheumatol 2019; 46: 1134-40. DOI: https://doi.org/10.3899/jrheum.170990

Turajane T, Wongbunnak R, Patchratrakul T, Ratansumawong K, Poigampetch Y, Songpatanasilp T. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and Cox-2 inhibitors in elderly patients with knee osteoarthritis. J Med Assoc Thai 2009; 92. DOI: https://doi.org/10.1016/S1098-3015(11)73337-X

Carr II JB, Rodeo SA. The role of biologic agents in the management of common shoulder pathologies: current state and future directions. J Shoulder Elbow Surg 2019; 28: 2041-52. DOI: https://doi.org/10.1016/j.jse.2019.07.025

Turajane T, Saengsirinavin P, Sriratanavudhi C, Larpaiwong W, Aojanepong J. A prospective, randomized, controlled trial comparing clinical outcomes of intraarticular platelet plasma concentrate and growth factors versus corticosteroid injections in the treatment of knee osteoarthritis. Bank Med J 2021; 17. DOI: https://doi.org/10.31524/bkkmedj.2021.11.002

Turajane T, Sriratanavudhi C, Saengsirinavin P, Chaweewannakorn U, Larpaiwong W, Aojanepong J. Safety and clinical efficacy of platelet rich growth factors (PRGF) in managing knee osteoarthritis after failed conservative treatment: evidence from real practices. J Southeast Asian Med Res 2019; 1: 1-7. DOI: https://doi.org/10.55374/jseamed.v3i1.43

Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007; 28: 4551-60. DOI: https://doi.org/10.1016/j.biomaterials.2007.06.037

Gobbi A, Karmatzikoz G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 2012; 4: 162-72. DOI: https://doi.org/10.1177/1941738111431801

Turajane T, Chaweewannakorn U, Larbpai boonpong V, Aojanepong J, Thitiset T, Honsawek S et al. Combination of intraarticular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease. J Med Assoc Thai 2012; 96.

Turajane T, Thitiset T, Honsawek S, Chaweewannakorn U, Aojanepong J, Papadopoulos KI. Assessment of chrondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold. Musculoskelet 2014; 98: 35-43. DOI: https://doi.org/10.1007/s12306-013-0303-y

Lee H, Park KM, Joung YK, Park KD, Do SH. Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 2012; 159: 332-7 DOI: https://doi.org/10.1016/j.jconrel.2012.02.008

Sundman EA, Cole BJ, Karas V, Valle CD, Tetreault MW, Mohammed HO, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 2014; 42: 35-41. DOI: https://doi.org/10.1177/0363546513507766

Filardo G, Kon E, Buda R, Timoncini A, Martino AD, Cenacchi A et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011; 19: 528-35. DOI: https://doi.org/10.1007/s00167-010-1238-6

Vilchez-Cavazos F, Millan-Alanis JM, Blazquez-Saldana J, Alvarez-Villalobos NA, Pena-Martinez VM, Acosta-Olivo CA, et al. Comparison of the clinical effectiveness of single versus multiple injections of plateletrich plasma in the treatment of knee osteoarthritis. Ortho J Sports Med 2019; 7: 2325967119887116. DOI: https://doi.org/10.1177/2325967119887116

Laver L, Maron N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage 2017; 4: 341-64. DOI: https://doi.org/10.1177/1947603516670709

Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 2014; 7: 189-97. DOI: https://doi.org/10.4103/0974-2077.150734

Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect. J Bone Joint Surg 2018; 7: 1-11. DOI: https://doi.org/10.2106/JBJS.RVW.17.00167

Published
2022-04-12
How to Cite
1.
Turjane T, Saengsirinavin P, Sriratanavudhi C, Cheeva-akrapan V, Larpaiwong W, Aojanepong J. OUTCOME OF USING PLATELET, PLASMA AND GROWTH FACTORS AS AN ORTHOBIOLOGIC DERIVATIVE TO AVOID INVASIVE SURGICAL PROCEDURES FOR TREATING KNEE OSTEOARTHRITIS AMONG ELDERLY PATIENTS. J Southeast Asian Med Res [Internet]. 2022Apr.12 [cited 2022Aug.9];60:e0105. Available from: https://www.jseamed.org/index.php/jseamed/article/view/105
Section
Original Articles